Neurogenic abnormalities in masked hypertension - PubMed (original) (raw)
Neurogenic abnormalities in masked hypertension
Guido Grassi et al. Hypertension. 2007 Sep.
Abstract
Patients with hypertension exhibit an increased sympathetic activity. No information exists as to whether this is the case in normotensive individuals in whom there is an increased ambulatory blood pressure, a condition termed "masked" hypertension. We studied 18 middle-aged subjects with masked hypertension in whom we measured muscle sympathetic nerve traffic (peroneal nerve and microneurography) and beat-to-beat arterial blood pressure at rest and during baroreceptor deactivation and activation. Measurements also included anthropometric values and insulin sensitivity (homeostasis model assessment index). Data were compared with those of 20 normotensive subjects, 18 subjects with white-coat hypertension, and 20 patients with "in-office" and "out-of-office" hypertension. All of the individuals were pharmacologically untreated and age-matched with subjects with masked hypertension. Patients with in- and out-of-office and white-coat hypertension displayed resting sympathetic nerve activity values significantly greater than normotensive subjects (75.8+/-2.5 and 70.8+/-2.2 versus 45.5+/-2.0 bursts per 100 heartbeats respectively; P<0.01). This was the case also for masked hypertension (73.5+/-2.4 bursts per 100 heartbeats; P<0.01), the degree of the sympathetic activation being similar for magnitude to that seen in the other 2 hypertensive conditions. Compared with normotensive subjects, baroreflex-heart rate control was significantly attenuated in all of the hypertensive states, whereas baroreflex-sympathetic control was unaffected. Homeostasis model assessment index was increased in patients with in- and out-of-office and white-coat hypertension, with a further increase in masked hypertension and a direct relation with resting sympathetic nerve traffic (r=0.46; P<0.01). These data provide the first evidence that masked hypertension is characterized by a marked sympathetic overdrive. They further show that the neurogenic alterations are coupled with metabolic and baroreflex abnormalities.
Similar articles
- Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction.
Grassi G, Seravalle G, Quarti-Trevano F, Dell'Oro R, Arenare F, Spaziani D, Mancia G. Grassi G, et al. Hypertension. 2009 Feb;53(2):205-9. doi: 10.1161/HYPERTENSIONAHA.108.121467. Epub 2009 Jan 5. Hypertension. 2009. PMID: 19124679 - Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives.
Grassi G, Seravalle G, Quarti-Trevano F, Dell'Oro R, Bombelli M, Cuspidi C, Facchetti R, Bolla G, Mancia G. Grassi G, et al. Hypertension. 2008 Nov;52(5):925-31. doi: 10.1161/HYPERTENSIONAHA.108.116368. Epub 2008 Sep 8. Hypertension. 2008. PMID: 18779438 - Sympathetic nerve traffic and baroreflex function in optimal, normal, and high-normal blood pressure states.
Seravalle G, Lonati L, Buzzi S, Cairo M, Quarti Trevano F, Dell'Oro R, Facchetti R, Mancia G, Grassi G. Seravalle G, et al. J Hypertens. 2015 Jul;33(7):1411-7. doi: 10.1097/HJH.0000000000000567. J Hypertens. 2015. PMID: 25827432 - Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives.
Grassi G. Grassi G. Hypertension. 2009 Oct;54(4):690-7. doi: 10.1161/HYPERTENSIONAHA.108.119883. Epub 2009 Aug 31. Hypertension. 2009. PMID: 19720958 Review. - Use of microneurography to evaluate sympathetic activity in hypertension: a brief review.
Yucha CB. Yucha CB. Appl Psychophysiol Biofeedback. 2000 Mar;25(1):55-63. doi: 10.1023/a:1009537506603. Appl Psychophysiol Biofeedback. 2000. PMID: 10832510 Review.
Cited by
- The association between depressive symptoms and masked hypertension in participants with normotension measured at research center.
Tokioka S, Nakaya N, Nakaya K, Kogure M, Hatanaka R, Chiba I, Kanno I, Nochioka K, Metoki H, Murakami T, Satoh M, Nakamura T, Ishikuro M, Obara T, Hamanaka Y, Orui M, Kobayashi T, Uruno A, Kodama EN, Nagaie S, Ogishima S, Izumi Y, Fuse N, Kuriyama S, Hozawa A. Tokioka S, et al. Hypertens Res. 2024 Mar;47(3):586-597. doi: 10.1038/s41440-023-01484-8. Epub 2023 Oct 31. Hypertens Res. 2024. PMID: 37907602 Free PMC article. - Effects of Nondipping Blood Pressure Changes: A Nephrologist Prospect.
Habas E Sr, Akbar RA, Alfitori G, Farfar KL, Habas E, Errayes N, Habas A, Al Adab A, Rayani A, Geryo N, Elzouki AY. Habas E Sr, et al. Cureus. 2023 Jul 30;15(7):e42681. doi: 10.7759/cureus.42681. eCollection 2023 Jul. Cureus. 2023. PMID: 37649932 Free PMC article. Review. - A multiscale predictive digital twin for neurocardiac modulation.
Yang PC, Rose A, DeMarco KR, Dawson JRD, Han Y, Jeng MT, Harvey RD, Santana LF, Ripplinger CM, Vorobyov I, Lewis TJ, Clancy CE. Yang PC, et al. J Physiol. 2023 Sep;601(17):3789-3812. doi: 10.1113/JP284391. Epub 2023 Aug 1. J Physiol. 2023. PMID: 37528537 Free PMC article. - Masked Hypertension and Exaggerated Blood Pressure Response to Exercise: A Review and Meta-Analysis.
Cuspidi C, Gherbesi E, Faggiano A, Sala C, Carugo S, Grassi G, Tadic M. Cuspidi C, et al. Diagnostics (Basel). 2023 Mar 7;13(6):1005. doi: 10.3390/diagnostics13061005. Diagnostics (Basel). 2023. PMID: 36980313 Free PMC article. Review. - Assessment of plasma catecholamines in patients with dysmetabolic iron overload syndrome.
Hanna HWZ, Baz HN, Al-Kzayer LFY, El Haddad HE, El-Mougy F. Hanna HWZ, et al. J Appl Biomed. 2022 Dec;20(4):141-145. doi: 10.32725/jab.2022.016. Epub 2022 Dec 2. J Appl Biomed. 2022. PMID: 36708719
MeSH terms
LinkOut - more resources
Full Text Sources
Medical